Prevalence of Maternal Anemia in Southern Jordan: Findings from a Cross-Sectional Study and 5-Year Review
Abstract
:1. Introduction
2. Materials and Methods
2.1. Study Area, Population, and Design
2.2. Inclusion and Exclusion Criteria and Study Sampling
- n = required sample size;
- Z = desired confidence level (for a 95% confidence interval, Z was typically 1.96);
- p = prevalence of anemia from previous studies (56.5%);
- 1 − p = proportion of the population without anemia;
- E = margin of error (0.05).
2.3. Data Collection
2.4. Study Variables
2.4.1. Explanatory Variables
2.4.2. Outcome Variable
2.4.3. Definitions of Variables
2.5. Statistical Analysis
2.6. Research Ethical Approval
3. Results
3.1. Anemia Prevalence and Severity
3.2. Sociodemographic, Medical, and Diet-Related Characteristics
3.3. Obstetric Characteristics
3.4. Sociodemographic, Economic, Medical, and Diet-Related Predictors of Anemia
3.5. Obstetric Predictors of Anemia
3.5.1. Prevalence and Degree of Anemia Among Pregnant Adolescents
3.5.2. Sociodemographic, Diet-Related, and Obstetric Characteristics of the Adolescent Respondents
4. Discussion
4.1. Socioeconomic and Demographic Determinants
4.2. Nutritional, Micronutrient Status and Preventive Measures
4.3. Non-Supplemental Factors Contributing to Maternal Anemia
4.4. Adolescent Pregnancy: Trends and Implications
4.5. Strengths and Limitations
5. Conclusions
Author Contributions
Funding
Institutional Review Board Statement
Informed Consent Statement
Data Availability Statement
Acknowledgments
Conflicts of Interest
References
- Current Trends CDC Criteria for Anemia in Children and Childbearing-Aged Women. Arch. Pediatr. Adolesc. Med. 1990, 144, 151–152. [CrossRef]
- Stevens, G.A.; Finucane, M.M.; De-Regil, L.M.; Paciorek, C.J.; Flaxman, S.R.; Branca, F.; Peña-Rosas, J.P.; Bhutta, Z.A.; Ezzati, M.; Nutrition Impact Model Study Group (Anaemia). Global, regional, and national Trends in haemoglobin concentration and prevalence of total and severe anaemia in children and pregnant and non-pregnant women for 1995–2011: A systematic analysis of population-representative data. Lancet Glob. Health 2013, 1, e16–e25. [Google Scholar] [CrossRef] [PubMed]
- Young, M.F.; Oaks, B.M.; Rogers, H.P.; Tandon, S.; Martorell, R.; Dewey, K.G.; Wendt, A.S. Maternal low and high hemoglobin concentrations and associations with adverse maternal and infant health outcomes: An updated global systematic review and meta-analysis. BMC Pregnancy Childbirth 2023, 23, 264. [Google Scholar] [CrossRef] [PubMed]
- Indicator Group Details. Available online: https://www.who.int/data/gho/data/themes/topics/indicator-groups/indicator-group-details/GHO/prevalence-of-anaemia-in-pregnant-women (accessed on 27 July 2024).
- GBD 2019 Risk Factors Collaborators. Global Burden of 87 Risk Factors in 204 Countries and Territories, 1990–2019: A Systematic Analysis for the Global Burden of Disease Study 2019. Lancet 2020, 396, 1223–1249. [Google Scholar] [CrossRef] [PubMed]
- Liu, R.; Pi, L.; Leng, F.; Shen, Q. Global disability-adjusted life years and deaths attributable to child and maternal Malnutrition from 1990 to 2019. Front. Public Health 2024, 12, 1323263. [Google Scholar] [CrossRef]
- WHO. Global Nutrition Targets 2025: Anaemia Policy Brief (WHO/NMH/NHD/14.4); World Health Organization: Geneva, Switzerland, 2014. [Google Scholar]
- United Nations Department of Economic and Social Affairs. The Millennium Development Goals Report 2015; Millennium Development Goals Report; United Nations Department of Economic and Social Affairs: New York, NY, USA, 2016. [Google Scholar] [CrossRef]
- Department of Statistics [Jordan]; ICF. Jordan Population and Family Health Survey 2017–2018: Key Findings; DOS and ICF: Amman, Jordan; Rockville, MD, USA, 2019. [Google Scholar]
- The Jordan National Micronutrient Survey (JNMNS) 2019; UNICEF: Amman, Jordan, 2019; Available online: https://www.unicef.org/jordan/reports/jordan-national-micronutrient-survey-jnmns-2019 (accessed on 1 August 2024).
- Jordan Department of Statistics. Population Estimates of The Kingdom by Municipality and Sex, for End of Year 2023. 2024. Available online: https://dosweb.dos.gov.jo/DataBank/Population/Population_Estimares/Municipalities.pdf (accessed on 27 July 2024).
- WHO Consultation on Obesity (1999: Geneva, Switzerland) & World Health Organization. Obesity: Preventing and Managing the Global Epidemic: Report of a WHO Consultation. World Health Organization. 2000. Available online: https://iris.who.int/handle/10665/42330 (accessed on 1 August 2024).
- World Health Organization. Haemoglobin Concentrations for the Diagnosis of Anaemia and Assessment of Severity. Vitamin and Mineral Nutrition Information System; World Health Organization: Geneva, Switzerland, 2011; Available online: https://www.who.int/publications/i/item/WHO-NMH-NHD-MNM-11.1 (accessed on 6 December 2024).
- WHO Recommendations on Antenatal Care for a Positive Pregnancy Experience. 2016. Available online: http://www.who.int/reproductivehealth/publications/maternal_perinatal_health/anc-positive-pregnancy-experience/en/ (accessed on 17 November 2024).
- Global Multidimensional Poverty Index 2023: Unstacking Global Poverty—Data for High-Impact Action | OPHI. Available online: https://ophi.org.uk/Publications/GMPI14-2023 (accessed on 26 November 2024).
- Report of a WHO Technical Consultation on Birth Spacing: Geneva, Switzerland 13–15 June 2005. 2007. Available online: https://www.who.int/publications/i/item/WHO-RHR-07.1 (accessed on 1 August 2024).
- World Health Organization. Adolescent Pregnancy Fact Sheet. Available online: https://iris.who.int/bitstream/handle/10665/112320/?sequence=1 (accessed on 21 July 2024).
- Al-Mehaisen, L.; Khader, Y.; Al-Kuran, O.; Abu Issa, F.; Amarin, Z. Maternal Anemia in Rural Jordan: Room for Improvement. Anemia 2011, 2011, 381812. [Google Scholar] [CrossRef]
- Abujilban, S.; Hatamleh, R.; Al-Shuqerat, S. The impact of a planned health educational program on the compliance and knowledge of Jordanian pregnant women with anemia. Women Health 2018, 59, 748–759. [Google Scholar] [CrossRef]
- Maaita, M.; Irtaimeh, T.; Altaleb, N.; Ibrahim, R.; Odeh, R. Perception of Iron Deficiency Anemia. (IDA) and Compliance of Iron Supplements among Pregnant Women Admitted to the Labor Ward at King Hussein Medical Center, Amman, Jordan. Jordan Med. J. 2018, 25, 12–18. [Google Scholar]
- Kilbride, J.; Baker, T.G.; Parapia, L.A.; Khoury, S.A. Iron Status, Serum Folate and B12 Values in Pregnancy and Postpartum: Report from a Study in Jordan. Ann. Saudi Med. 2000, 20, 371–376. [Google Scholar] [CrossRef]
- Jarrah, S.S.; Halabi, J.O.; Bond, A.E.; Abegglen, J. Iron Deficiency Anemia (IDA) Perceptions and Dietary Iron Intake Among Young Women and Pregnant Women in Jordan. J. Transcult. Nurs. 2007, 18, 19–27. [Google Scholar] [CrossRef]
- Awidi, M.; Bawaneh, H.; Zureigat, H.; AlHusban, M.; Awidi, A. Contributing factors to iron deficiency anemia in women in Jordan: A single-center cross-sectional study. PLoS ONE 2018, 13, e0205868. [Google Scholar] [CrossRef] [PubMed]
- Abdo, N.; Douglas, S.; Batieha, A.; Khader, Y.; Jaddou, H.; Al-Khatib, S.; El-Khatib, M.; AbuZaid, H.; Ajlouni, K. The prevalence and determinants of anaemia in Jordan. East. Mediterr. Health J. 2019, 25, 341–349. [Google Scholar] [CrossRef] [PubMed]
- Salahat, M.A.; Ibrahim, A.I. Prevalence of Anemia among Jordanian Pregnant Women and the Effect of Early Pregnancy on Alkaline Phosphatase Activity. Jordan J. Biol. Sci. 2012, 5, 65–70. [Google Scholar]
- Karami, M.; Chaleshgar, M.; Salari, N.; Akbari, H.; Mohammadi, M. Global Prevalence of Anemia in Pregnant Women: A Comprehensive Systematic Review and Meta-Analysis. Matern. Child Health J. 2022, 26, 1473–1487. [Google Scholar] [CrossRef]
- Department of Statistics, Jordan. Jordan Statistical Yearbook 2022. Available online: https://dosweb.dos.gov.jo/databank/yearbook/YearBook2022-4.pdf (accessed on 25 November 2024).
- International Federation of Gynecology and Obstetrics. Iron Deficiency and Anaemia in Women and Girls. 2023. Available online: https://www.figo.org/resources/figo-statements/iron-deficiency-and-anaemia-women-and-girls (accessed on 17 November 2024).
- Hansen, R.; Sejer, E.P.F.; Holm, C.; Schroll, J.B. Iron supplements in pregnant women with normal iron status: A systematic review and meta-analysis. Acta Obstet. Gynecol. Scand. 2023, 102, 1147–1158. [Google Scholar] [CrossRef]
- World Health Organization. Archived: Iron Deficiency Anaemia: Assessment, Prevention, and Control; WHO/NHD/01.3; World Health Organization: Geneva, Switzerland, 2001. [Google Scholar]
- Talin, I.A.; Abid, M.H.; Samad, M.A.; Domínguez Azpíroz, I.; de la Torre Diez, I.; Ashraf, I.; Nahid, A.A. Exploring factors influencing the severity of pregnancy anemia in India: A study using proportional odds model. Sci. Rep. 2023, 13, 22816. [Google Scholar] [CrossRef]
- Al-Rumhi, A.A.S.; Arulappan, J.; Al-Hashmi, I. Short interpregnancy interval and adverse pregnancy outcomes among women in a Middle Eastern country. Br. J. Midwifery 2023, 31, 325–335. [Google Scholar] [CrossRef]
- Mruts, K.B.; Gebremedhin, A.T.; Tessema, G.A.; Scott, J.A.; Pereira, G. Interbirth interval and maternal anaemia in 21 sub-Saharan African countries: A fractional-polynomial analysis. PLoS ONE 2022, 17, e0275155. [Google Scholar] [CrossRef] [PubMed]
- Mahfouz, E.; El-Sherbiny, N.; Hamed, W. Effect of inter-pregnancy interval on pregnancy outcome: A prospective study at Fayoum, Egypt. Int. J. Med. Dev. Ctries. 2018, 2, 38–44. [Google Scholar] [CrossRef]
- Khader, Y.S.; Batieha, A.; Al Fursan, R.K.; Al-Hader, R.; Hijazi, S.S. Rate of teenage pregnancy in Jordan and its impact on maternal and neonatal outcomes. Int. J. Adolesc. Med. Health 2017, 31, 20170075. [Google Scholar] [CrossRef]
- Mina, M.N.; Nuruzzaman, M.; Habib, M.N.; Rahman, M.; Chowdhury, F.M.; Ahsan, S.N.; Ahmed, F.F.; Azizi, S.; Mubin, N.; Kibria, A.G.; et al. The Effectiveness of Adequate Antenatal Care in Reducing Adverse Perinatal Outcomes: Evidence From a Low- or Middle-Income Country. Cureus 2023, 15, e51254. [Google Scholar] [CrossRef] [PubMed]
- World Health Organization. Adolescent Pregnancy (Issues in Adolescent Health and Development); WHO: Geneva, Switzerland, 2004; Available online: https://iris.who.int/bitstream/handle/10665/42903/9241591455_eng.pdf (accessed on 18 November 2024).
Variable | Frequency | Median (Mean ± SD 1) | Hemoglobin Level (gm/dL) 11.6 (11.42 ± 1.43) | p-Value | |||
---|---|---|---|---|---|---|---|
<7 Severe | 7–9.9 Moderate | 10–10.9 Mild | >11 Normal | ||||
Age | 30 (29.09 ± 6.34) | ||||||
<20 | 25 (5.3) | 0 | 4 (16) | 8 (32) | 13 (52) | 0.910 | |
20–25 | 120 (25.3) | 17 (14.2) | 24 (20) | 79 (65.8) | |||
26–34 | 225 (47.5) | 31 (13.8) | 50 (22.2) | 144 (64) | |||
35–45 | 104 (21.9) | 17(16.4) | 23(22.1) | 64 (61.5) | |||
BMI 2 (kg/m2) | 24.9 (26.32 ± 6.24) | ||||||
<18.5 | 47 (9.9) | 0 | 7 (14.9) | 13 (27.7) | 27 (57.4) | 0.348 | |
18.5–24.9 | 191 (40.3) | 32 (16.8) | 43 (22.5) | 116 (60.7) | |||
25–29.9 | 134 (28.3) | 19 (14.1) | 25 (18.7) | 90 (67.2) | |||
30–34.9 | 34 (7.2) | 6 (17.6) | 9 (26.5) | 19 (55.9) | |||
≥35 | 68 (14.3) | 5 (7.3) | 15 (22.1) | 48 (70.6) | |||
District | |||||||
Al Karak | 385 (81.2) | 0 | 15 (3.9) | 119 (30.9) | 251 (65.2) | 0.040 * | |
Al Qatranah | 21 (4.4) | 2 (9.5) | 8 (38.1) | 11 (52.4) | |||
Ghor Al Safi | 39 (8.2) | 2 (5.1) | 22 (56.4) | 15 (38.5) | |||
Al Tafilah | 29 (6.2) | 2 (6.9) | 7 (24.1) | 20 (69.0) | |||
Education | |||||||
Elementary | 92 (19.4) | 0 | 11 (12) | 42 (45.7) | 39 (42.4) | <0.001 * | |
Secondary | 192 (40.5) | 7 (3.7) | 69 (36.3) | 114 (60) | |||
University | 190 (40.1) | 2 (1) | 43 (22.4) | 147 (76.6) | |||
Employment | |||||||
No | 377 (79.5) | 0 | 230 (61) | 128 (34) | 19 (5) | 0.042 * | |
Yes | 97 (20.5) | 70 (72.2) | 26 (26.8) | 1 (1) | |||
Household income/JOD 3 | 350 (373.21 ± 216.40) | ||||||
<200 | 150 (31.6) | 0 | 36 (24) | 47 (31.3) | 67 (44.7) | <0.001 * | |
200–500 | 250 (52.7) | 29 (11.6) | 44 (17.6) | 177 (70.8) | |||
501–1000 | 70 (14.8) | 4 (5.7) | 14 (20) | 52 (74.3) | |||
>1000 | 4 (0.8) | 0 | 0 | 4 (100) | |||
Family size | 3 (4.05 ± 2.12) | ||||||
Two | 142 (30) | 0 | 18 (12.7) | 26 (18.3) | 98 (69) | 0.223 | |
Three | 100 (21.1) | 15 (15) | 20 (20) | 65 (65) | |||
Four | 84 (17.7) | 15 (17.9) | 17 (20.2) | 52 (61.9) | |||
≥Five | 148 (31.2) | 21 (14.2) | 42 (28.4) | 85 (57.4) | |||
Daily tea intake | |||||||
None | 234 (49.4) | 0 | 39 (16.7) | 49 (20.9) | 146 (62.4) | 0.267 | |
Once | 139 (29.3) | 15 (10.8) | 29 (20.9) | 95 (68.3) | |||
Multiple | 101 (21.3) | 15 (14.9) | 27 (26.7) | 59 (58.4) | |||
Meals/day | |||||||
Once | 54 (11.4) | 0 | 22 (40.7) | 11 (20.4) | 21 (38.9) | 0.001 * | |
Twice | 191 (40.3) | 22 (11.5) | 39 (20.4) | 130 (68.1) | |||
3 times | 187 (39.5) | 19 (10.2) | 48 (25.7) | 120 (64.1) | |||
≥4 times | 42 (8.9) | 6 (14.3) | 7 (16.7) | 29 (69) | |||
Meat intake | |||||||
Daily | 17 (3.6) | 0 | 1 (5.9) | 4 (23.5) | 12 (70.6) | <0.001 * | |
Twice/week | 75 (15.8) | 3 (4) | 14 (18.7) | 58 (77.3) | |||
Once/week | 161 (34) | 15 (9.3) | 29 (18) | 117 (72.7) | |||
1–3 times/month | 221 (46.6) | 50 (22.6) | 58 (26.2) | 113 (51.1) | |||
Smoking | |||||||
Active | |||||||
No | 457 (96.4) | 0 | 20 (4.4) | 148 (32.4) | 289 (63.2) | 0.561 | |
Yes | 17 (3.6) | 1 (5.8) | 5 (29.4) | 11 (64.7) | |||
Passive | |||||||
No | 138 (29.1) | 0 | 6 (4.3) | 38 (27.5) | 94 (68.1) | 0.174 | |
Yes | 336 (70.9) | 14 (4.2) | 116 (34.5) | 206 (61.3) | |||
Medical Comorbidities | |||||||
No | 441 (93) | 0 | 61 (13.8) | 100 (22.7) | 280 (63.5) | 0.852 | |
Yes | 33 (7.0) | 8 (24.2) | 5 (15.2) | 20 (60.6) | |||
Hemorrhoids | |||||||
No | 422 (89) | 0 | 60 (14.2) | 96 (22.8) | 266 (63) | 0.879 | |
Yes | 52 (11) | 9 (13.3) | 9 (13.3) | 34 (65.4) | |||
Peptic ulcer | |||||||
No | 439 (92.6) | 0 | 73 (16.6) | 85 (19.4) | 281 (64) | 0.276 | |
Yes | 35 (7.4) | 6 (17.1) | 10 (28.6) | 19 (54.3) |
Variable | Frequency | Median (Mean ± SD 1) | Hemoglobin Level (gm/dL) 11.6 (11.42 ± 1.43) | p-Value | |||
---|---|---|---|---|---|---|---|
<7 Severe | 7–9.9 Moderate, n (%) | 10–10.9 Mild, n (%) | >11 Normal, n (%) | ||||
Gestational age | 28 (25.24 ± 7.87) | ||||||
First trimester | 60 (12.7) | 0 | 2 (3.3) | 17 (28.3) | 41 (68.3) | 0.163 | |
Second trimester | 173 (36.5) | 12 (6.9) | 44 (25.4) | 117 (67.6) | |||
Third trimester | 241 (50.8) | 6 (2.5) | 93 (38.6) | 142 (58.9) | |||
Total | 474 | 20 | 154 | 300 | |||
Parity | 1 (2.03 ± 2.10) | ||||||
Primigravida | 143 (30.1) | 0 | 18 (12.6) | 27 (18.9) | 98 (68.5) | 0.278 | |
1–4 | 253 (53.4) | 43 (17) | 57 (22.5) | 153 (60.5) | |||
≥5 | 78 (16.5) | 8 (10.3) | 21 (26.9) | 49 (62.8) | |||
Total | 474 | 69 | 105 | 300 | |||
Interpregnancy interval | n (% Multiparous = 331) | ||||||
<1 year | 118 (35.6) | 0 | 18 (15.2) | 37 (31.4) | 63 (53.4) | 0.159 | |
1–2 years | 80 (24.2) | 12 (15) | 16 (20) | 52 (65) | |||
>2 years | 133 (40.2) | 21 (15.8) | 26 (19.5) | 86 (64.7) | |||
Total | 331 | 51 | 79 | 201 | |||
Antenatal care | |||||||
Regular | 356 (75.1) | 0 | 9 (2.5) | 101 (28.4) | 246 (69.1) | <0.001 * | |
Irregular | 118 (24.9) | 11 (9.3) | 53 (44.9) | 54 (45.8) | |||
Total | 474 | 20 | 154 | 300 | |||
Previous C/S 2 | n (% Multiparous = 331) | ||||||
No | 126 (38.1) | 0 | 20 (15.9) | 30 (23.8) | 76 (60.3) | 0.213 | |
Yes | 205 (61.9) | 35 (17.1) | 48 (23.4) | 122 (59.5) | |||
Total | 331 | 55 | 78 | 198 | |||
Folic acid intake | |||||||
No | 29 (6.1) | 0 | 6 (20.7) | 15 (51.7) | 8 (27.6) | <0.001 * | |
Yes | 445 (93.9) | 14 (3.1) | 139 (31.2) | 292 (65.6) | |||
Total | 474 | 20 | 154 | 300 | |||
Iron supplement | |||||||
No | 170 (35.9) | 0 | 15 (8.8) | 60 (35.3) | 95 (55.9) | 0.010 * | |
Yes | 304 (64.1) | 5 (1.6) | 94 (30.9) | 205 (67.4) | |||
Total | 474 | 20 | 154 | 300 | |||
Vitamin supplements | |||||||
No | 180 (38) | 0 | 14 (7.8) | 80 (44.4) | 86 (47.8) | <0.001 * | |
Yes | 294 (62) | 6 (2.0) | 74 (25.2) | 214 (72.8) | |||
Total | 474 | 20 | 154 | 300 |
Variable | Categories | AOR 1 (95% CI 2) | p-Value |
---|---|---|---|
District | Al Karak | 1 | |
Al Qatranah | 1.289 (0.666, 2.496) | 0.531 | |
Ghor Al Safi | 1.722 (1.244, 2.384) | 0.014 * | |
Al Tafilah | 0.788 (0.370, 1.678) | 0.619 | |
Education | Elementary | 1 | |
Secondary | 0.694 (0.542, 0.889) | 0.007 * | |
University | 0.407 (0.298, 0.555) | <0.001 * | |
Employment | Yes | 0.603 (0.370, 0.985) | 0.045 * |
No | 1 | ||
Household income/JOD 3 | <200 | 1 | |
200–500 | 0.333 (0.218, 0.508) | <0.001 * | |
501–1000 | 0.279 (0.150, 0.522) | <0.001 * | |
>1000 | No anemia cases | No anemia cases | |
Meals/day | Once | 1 | |
Twice | 0.299 (0.160, 0.558) | <0.001 * | |
3 times | 0.355 (0.190, 0.663) | 0.002 * | |
≥4 times | 0.285 (0.122, 0.669) | 0.004 * | |
Meat intake | Daily | 0.436 (0.149, 1.279) | 0.138 |
Twice/week | 0.307 (0.168, 0.560) | <0.001 * | |
Once/week | 0.393 (0.255, 0.608) | <0.001 * | |
1–3 times/month | 1 |
Variable | Categories | AOR 1 (95% CI 2) | p-Value |
---|---|---|---|
Antenatal care | Regular | 0.457 (0.293, 0.715) | 0.001 * |
Irregular | 1 | ||
Folic acid intake | Yes | 0.327 (0.135, 0.794) | 0.014 * |
No | 1 | ||
Iron supplement | Yes | 1.230 (0.749, 2.021) | 0.413 * |
No | 1 | ||
Vitamin supplement | Yes | 0.382 (0.235, 0.621) | <0.001 * |
No | 1 |
Variable | Frequency (%) | Hemoglobin Level (gm/dL) | |||
---|---|---|---|---|---|
<7 Severe | 7–9.9 Moderate, n (%) | 10–10.9 Mild, n (%) | >11 Normal, n (%) | ||
BMI 1 (kg/m2) | |||||
<18.5 | 5 (20) | 0 | 1 (20) | 3 (60) | 1 (20) |
18.5–24.9 | 11 (44) | 1 (9.1) | 3 (27.3) | 7 (63.6) | |
25–29.9 | 7 (28) | 1 (14.3) | 1 (14.3) | 5 (71.4) | |
30–34.9 | 2 (8) | 0 | 1 (50) | 1 (50) | |
District | |||||
Karak | 13 (52) | 0 | 2 (15.4) | 5 (38.5) | 6 (46.2) |
Al Qatranah | 4 (16) | 1 (25) | 1 (25) | 2 (50) | |
Ghor Al Safi | 6 (24) | 2 (33.3) | 2 (33.3) | 2 (33.3) | |
Tafilah | 2 (8) | 0 | 1 (50) | 1 (50) | |
Education | |||||
Elementary | 15 (60) | 0 | 2 (13.3) | 7 (46.7) | 6 (40) |
Secondary | 10 (40) | 2 (20) | 2 (20) | 6 (60) | |
Employment | |||||
No | 25 (100) | 0 | 4 (16) | 8 (32) | 13 (52) |
Household income/JOD 2 | |||||
<200 | 11 (44) | 0 | 2 (18.2) | 5 (45.5) | 4 (36.3) |
200–500 | 14 (56) | 1 (7.1) | 4 (28.6) | 9 (64.3) | |
Family size | |||||
Two | 17 (68) | 0 | 3 (17.7) | 4 (23.5) | 10 (58.8) |
Three | 5 (20) | 0 | 4 (80) | 1 (20) | |
Four | 3 (12) | 1 (33.3) | 1 (33.3) | 1 (33.3) | |
Daily tea intake | |||||
None | 8 (32) | 0 | 1 (12.5) | 3 (37.5) | 4 (50) |
Once | 12 (48) | 1 (8.3) | 4 (33.3) | 7 (58.4) | |
multiple | 5 (20) | 1 (20) | 2 (40) | 2 (40) | |
Meals/day | |||||
Once | 4 (16) | 0 | 0 | 3 (75) | 1 (25) |
Twice | 6 (24) | 0 | 1 (16.7) | 5 (83.3) | |
3 times | 13 (52) | 2 (15.3) | 6 (46.2) | 5 (38.5) | |
≥4 times | 2 (8) | 1 (50) | 0 | 1 (50) | |
Meat intake | |||||
Once/week | 10 (40) | 0 | 1 (10) | 3 (30) | 6 (60) |
1–3 times/month | 15 (60) | 2 (13.3) | 6 (40) | 7 (46.7) | |
Smoking | |||||
Active | |||||
No | 23 (92) | 0 | 4 (17.4) | 8 (34.8) | 11 (47.8) |
Yes | 2 (8) | 0 | 0 | 2 (100) | |
Passive | |||||
No | 7 (28) | 0 | 1 (14.3) | 2 (28.6) | 4 (57.1) |
Yes | 18 (72) | 3 (16.7) | 6 (33.3) | 9 (50) | |
Gestational age | |||||
Second trimester | 9 (36) | 0 | 0 | 5 (55.6) | 4 (44.4) |
Third trimester | 16 (64) | 4 (25) | 4 (25) | 8 (50) | |
Parity | |||||
Primigravida | 17 (68) | 0 | 3 (17.7) | 4 (23.5) | 10 (58.8) |
1–4 | 8 (32) | 0 | 5 (62.5) | 3 (37.5) | |
Interpregnancy interval | n (% Multiparous) | ||||
<1 year | 5 (62.5) | 0 | 0 | 4 (80) | 1 (20) |
1–2 years | 3 (37.5) | 0 | 1 (33.3) | 2 (66.7) | |
Antenatal care | |||||
Regular | 14 (56) | 0 | 1 (7.1) | 5 (35.7) | 8 (57.2) |
Irregular | 11 (44) | 3 (27.2) | 4 (36.4) | 4 (36.4) | |
Previous C/S 3 | n (% Multiparous) | ||||
No | 4 (50) | 0 | 0 | 1 (25) | 3 (75) |
Yes | 4 (50) | 0 | 4 (100) | 0 | |
Folic acid intake | |||||
No | 5 (20) | 0 | 0 | 3 (60) | 2 (40) |
Yes | 20 (80) | 3 (15) | 6 (30) | 11 (55) | |
Iron supplements | |||||
No | 9 (36) | 0 | 1 (11.1) | 3 (33.3) | 5 (55.6) |
Yes | 16 (64) | 2 (12.5) | 6 (37.5) | 8 (50) | |
Vitamin supplements | |||||
No | 12 (48) | 0 | 2 (16.6) | 5 (41.7) | 5 (41.7) |
Yes | 13 (52) | 1 (7.7) | 4 (30.8) | 8 (61.5) |
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2024 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
Al-Kharabsheh, A.M.; Alahmad, I.F.; Al-Tamimi, M.M.; Abufraijeh, S.M.; Alnawaiseh, N. Prevalence of Maternal Anemia in Southern Jordan: Findings from a Cross-Sectional Study and 5-Year Review. Healthcare 2024, 12, 2495. https://doi.org/10.3390/healthcare12242495
Al-Kharabsheh AM, Alahmad IF, Al-Tamimi MM, Abufraijeh SM, Alnawaiseh N. Prevalence of Maternal Anemia in Southern Jordan: Findings from a Cross-Sectional Study and 5-Year Review. Healthcare. 2024; 12(24):2495. https://doi.org/10.3390/healthcare12242495
Chicago/Turabian StyleAl-Kharabsheh, Ahlam M., Israa F. Alahmad, Malak M. Al-Tamimi, Seham M. Abufraijeh, and Nedal Alnawaiseh. 2024. "Prevalence of Maternal Anemia in Southern Jordan: Findings from a Cross-Sectional Study and 5-Year Review" Healthcare 12, no. 24: 2495. https://doi.org/10.3390/healthcare12242495
APA StyleAl-Kharabsheh, A. M., Alahmad, I. F., Al-Tamimi, M. M., Abufraijeh, S. M., & Alnawaiseh, N. (2024). Prevalence of Maternal Anemia in Southern Jordan: Findings from a Cross-Sectional Study and 5-Year Review. Healthcare, 12(24), 2495. https://doi.org/10.3390/healthcare12242495